GlaxoSmithKline Consumer Nigeria Plc recently released its financial statements for the year ended December 2017. Revenue increased from ₦14.3 billion in 2016 to ₦16 billion in 2017. Profit before tax also increased from ₦185 million in 2016 to ₦1.1billion in 2017. Profit after tax fell from ₦2.3 billion in 2016 to ₦486 million in 2017.


The company has declared a special dividend of ₦7.10 per share in addition to a final dividend of ₦0.40 per share

Here is a copy of the result.

Onome Ohwovoriole has a degree in Economics and Statistics from the University of Benin and prior to joining Nairametrics in December 2016 as Lead Analyst had stints in Publishing, Automobile Services, Entertainment and Leadership Training. He covers companies in the Nigerian corporate space, especially those listed on the Nigerian Stock Exchange (NSE). He also has a keen interest in new frontiers like Cryptocurrencies and Fintech. In his spare time, he loves to read books on finance, fiction as well as keep up with happenings in the world of international diplomacy. You can contact him via


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.